UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Acropolis Investment Management LLC

Acropolis Investment Management LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 1.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,847 shares of the healthcare conglomerate’s stock after selling 133 shares during the period. UnitedHealth Group accounts for about 0.5% of Acropolis Investment Management LLC’s holdings, making the stock its 22nd biggest holding. Acropolis Investment Management LLC’s holdings in UnitedHealth Group were worth $5,751,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in UNH. TimeScale Financial Inc. boosted its stake in shares of UnitedHealth Group by 276.9% in the third quarter. TimeScale Financial Inc. now owns 49 shares of the healthcare conglomerate’s stock valued at $25,000 after purchasing an additional 36 shares during the period. Pflug Koory LLC boosted its stake in shares of UnitedHealth Group by 160.0% in the third quarter. Pflug Koory LLC now owns 52 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 32 shares during the period. Belmont Capital LLC boosted its stake in shares of UnitedHealth Group by 294.1% in the third quarter. Belmont Capital LLC now owns 67 shares of the healthcare conglomerate’s stock valued at $34,000 after purchasing an additional 50 shares during the period. O Dell Group LLC boosted its stake in shares of UnitedHealth Group by 76.9% in the third quarter. O Dell Group LLC now owns 69 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 30 shares during the period. Finally, Legend Financial Advisors Inc. purchased a new position in shares of UnitedHealth Group in the third quarter valued at $37,000. 86.31% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of several recent analyst reports. Stephens reaffirmed an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a report on Tuesday, February 28th. Credit Suisse Group upped their price target on shares of UnitedHealth Group from $590.00 to $610.00 and gave the company an “outperform” rating in a report on Wednesday, December 7th. Raymond James cut shares of UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price target on the stock. in a report on Monday, November 21st. UBS Group cut their price target on shares of UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating on the stock in a report on Wednesday, January 18th. Finally, StockNews.com raised shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 11th. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $599.68.

UnitedHealth Group Stock Down 0.5 %

UnitedHealth Group stock opened at $469.50 on Friday. The company has a 50-day simple moving average of $483.26 and a 200-day simple moving average of $510.69. The firm has a market capitalization of $437.97 billion, a P/E ratio of 22.16, a P/E/G ratio of 1.32 and a beta of 0.69. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.77 and a current ratio of 0.77. UnitedHealth Group Incorporated has a one year low of $449.70 and a one year high of $558.10.

UnitedHealth Group (NYSE:UNH – Get Rating) last released its quarterly earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, topping the consensus estimate of $5.17 by $0.17. The business had revenue of $82.79 billion during the quarter, compared to analyst estimates of $82.53 billion. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The company’s quarterly revenue was up 12.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $4.48 earnings per share. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 24.91 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 21st. Investors of record on Monday, March 13th will be given a $1.65 dividend. The ex-dividend date of this dividend is Friday, March 10th. This represents a $6.60 dividend on an annualized basis and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio is presently 31.15%.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.